Borosil Scientific Limited (NSE:BOROSCI)
130.84
-0.20 (-0.15%)
Mar 7, 2025, 9:15 AM IST
Borosil Scientific Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2016 |
Operating Revenue | 4,233 | 3,946 | 980.43 | 1,062 | 651.95 | 490.57 | Upgrade
|
Other Revenue | 14.06 | 14.06 | 3.65 | 2.32 | 2.08 | - | Upgrade
|
Revenue | 4,247 | 3,960 | 984.08 | 1,064 | 654.02 | 490.57 | Upgrade
|
Revenue Growth (YoY) | 39.22% | 302.39% | -7.54% | 62.73% | 33.32% | 4.43% | Upgrade
|
Cost of Revenue | 1,542 | 1,469 | 444.72 | 473.04 | 291.11 | 210.85 | Upgrade
|
Gross Profit | 2,706 | 2,491 | 539.37 | 591.27 | 362.91 | 279.73 | Upgrade
|
Selling, General & Admin | 839.18 | 836.19 | 138.03 | 131.93 | 99.88 | 90.39 | Upgrade
|
Other Operating Expenses | 1,322 | 1,187 | 305.91 | 288.93 | 192.22 | 161.81 | Upgrade
|
Operating Expenses | 2,343 | 2,187 | 514.58 | 482.58 | 344.15 | 303.08 | Upgrade
|
Operating Income | 362.31 | 304.01 | 24.79 | 108.7 | 18.76 | -23.35 | Upgrade
|
Interest Expense | -17.74 | -27.02 | -3.28 | -3.12 | -6.33 | -8.88 | Upgrade
|
Interest & Investment Income | 24.65 | 24.65 | 0.74 | 0.37 | 0.71 | 0.67 | Upgrade
|
Currency Exchange Gain (Loss) | 5.41 | 5.41 | 1.07 | 2.16 | 0.3 | -0.1 | Upgrade
|
Other Non Operating Income (Expenses) | 33.34 | 6.49 | 3.54 | 4.55 | 1.42 | - | Upgrade
|
EBT Excluding Unusual Items | 407.96 | 313.54 | 26.86 | 112.66 | 14.85 | -31.66 | Upgrade
|
Gain (Loss) on Sale of Investments | 2.45 | 2.45 | 3.06 | 0.55 | - | - | Upgrade
|
Gain (Loss) on Sale of Assets | -0.72 | -0.72 | -0.18 | - | - | - | Upgrade
|
Other Unusual Items | 0.14 | 0.14 | - | - | - | - | Upgrade
|
Pretax Income | 409.93 | 315.51 | 29.74 | 113.2 | 14.85 | -31.66 | Upgrade
|
Income Tax Expense | 134.27 | 80.7 | 9.1 | 27.53 | 2.58 | -9.72 | Upgrade
|
Earnings From Continuing Operations | 275.67 | 234.82 | 20.64 | 85.68 | 12.27 | -21.93 | Upgrade
|
Minority Interest in Earnings | -1.39 | 0.77 | - | - | - | - | Upgrade
|
Net Income | 274.28 | 235.59 | 20.64 | 85.68 | 12.27 | -21.93 | Upgrade
|
Net Income to Common | 274.28 | 235.59 | 20.64 | 85.68 | 12.27 | -21.93 | Upgrade
|
Net Income Growth | 87.89% | 1041.24% | -75.91% | 598.02% | - | - | Upgrade
|
Shares Outstanding (Basic) | 89 | 89 | 2 | 1 | 1 | 1 | Upgrade
|
Shares Outstanding (Diluted) | 89 | 89 | 2 | 1 | 1 | 1 | Upgrade
|
Shares Change (YoY) | 33.05% | 5334.22% | 12.33% | 4.08% | 10.19% | 41.00% | Upgrade
|
EPS (Basic) | 3.08 | 2.65 | 12.64 | 58.94 | 8.79 | -17.30 | Upgrade
|
EPS (Diluted) | 3.08 | 2.65 | 12.64 | 58.94 | 8.79 | -17.30 | Upgrade
|
EPS Growth | 41.00% | -79.03% | -78.55% | 570.67% | - | - | Upgrade
|
Free Cash Flow | - | 171.27 | -223.9 | -39.44 | 12.17 | -133.26 | Upgrade
|
Free Cash Flow Per Share | - | 1.93 | -137.11 | -27.13 | 8.71 | -105.13 | Upgrade
|
Gross Margin | 63.70% | 62.91% | 54.81% | 55.55% | 55.49% | 57.02% | Upgrade
|
Operating Margin | 8.53% | 7.68% | 2.52% | 10.21% | 2.87% | -4.76% | Upgrade
|
Profit Margin | 6.46% | 5.95% | 2.10% | 8.05% | 1.88% | -4.47% | Upgrade
|
Free Cash Flow Margin | - | 4.33% | -22.75% | -3.71% | 1.86% | -27.16% | Upgrade
|
EBITDA | 568.69 | 452.22 | 95.43 | 170.4 | 70.75 | 27.45 | Upgrade
|
EBITDA Margin | 13.39% | 11.42% | 9.70% | 16.01% | 10.82% | 5.60% | Upgrade
|
D&A For EBITDA | 206.38 | 148.21 | 70.64 | 61.71 | 51.99 | 50.8 | Upgrade
|
EBIT | 362.31 | 304.01 | 24.79 | 108.7 | 18.76 | -23.35 | Upgrade
|
EBIT Margin | 8.53% | 7.68% | 2.52% | 10.21% | 2.87% | -4.76% | Upgrade
|
Effective Tax Rate | 32.75% | 25.58% | 30.58% | 24.32% | 17.35% | - | Upgrade
|
Revenue as Reported | 4,314 | 4,000 | 992.49 | 1,072 | 657.45 | 494.21 | Upgrade
|
Advertising Expenses | - | 41.6 | 5.19 | 2.82 | 0.89 | 3.35 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.